Skip to main content
Log in

Proinsulin: recent observations and controversies

  • Published:
Cellular and Molecular Life Sciences CMLS Aims and scope Submit manuscript

Abstract.

Proinsulin has generally been regarded as an inert precursor to insulin. However, over the past few years, proinsulin has established itself as a useful research tool for understanding how cells synthesize and secrete peptide hormones. Last year, proinsulin attracted renewed interest for its role as the precursor to C peptide, which may prove useful in the treatment of patients suffering from insulin-dependent diabetes mellitus. This mini-review focuses on three aspects of proinsulin, each of which attracted attention in 1997. These three aspects illustrate how this peptide hormone precursor may yet prove to be more important than its primary role as a prohormone, with only one bioactive product, would suggest.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received 4 March 1998; received after revision 4 May 1998; accepted 4 May 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mackin, R. Proinsulin: recent observations and controversies. CMLS, Cell. Mol. Life Sci. 54, 696–702 (1998). https://doi.org/10.1007/s000180050196

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s000180050196

Navigation